HomeNewsBusinessEconomyADB downgrades Asia GDP forecast as China sticks to Covid Zero

ADB downgrades Asia GDP forecast as China sticks to Covid Zero

The bank expects the region to grow 4.6 percent this year compared to an earlier forecast of 5.2 percent

July 21, 2022 / 06:35 IST
Story continues below Advertisement

The Asian Development Bank cut its forecast for gross domestic product growth in developing Asia this year as China’s Covid Zero approach to containing the virus creates ripple effects on regional supply chains and economic development.

The bank expects the region to grow 4.6 percent this year compared to an earlier forecast of 5.2 percent, according to a report published Thursday.

Story continues below Advertisement

It slashed forecast for East Asia -including China, Hong Kong, Taiwan and South Korea -to 3.8 percent from 4.7 percent. Growth in China “will be weaker than earlier expected,” the bank said, projects GDP to expand 4 percent in 2022, down from an earlier estimate of 5 percent.

“With many economies in the region increasingly choosing to live with the virus and reopening, economic activity continued to expand in the first half of 2022 - with the notable exception” of China, the bank wrote in its report.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show